#ScientificSessions26 from @JAMA_current: Long-term follow-up in #ISCHEMIA-EXTEND indicates no significant all-cause mortality difference between initial invasive and conservative management of stable #CoronaryDisease.
ja.ma/4j4RAWI
📊 Research Summary: Among patients with stable #CoronaryDisease and moderate or severe ischemia, an initial invasive strategy did not improve long-term survival vs an initial conservative strategy.
ja.ma/3WxgIwG
#ScientificSessions26
📣 Stay connected with the JAMA Network at #ScientificSessions26!
Explore the latest cardiovascular research, featured articles, editor sessions, and attendee resources from the JAMA Network: ja.ma/4eY16Zp
From @JAMA_current: Among veterans with stable #CoronaryArteryDisease, upfront #PercutaneousCoronaryIntervention plus optimal medical therapy did not reduce long-term death or myocardial infarction vs optimal medical therapy alone.
ja.ma/3WzzW4M
#ScientificSessions26
📣 Stay connected with the JAMA Network at #ScientificSessions26!
Explore the latest cardiovascular research, featured articles, editor sessions, and attendee resources from the JAMA Network: ja.ma/4BUb6wQ
💬 Editorial from @JAMA_current: In patients with stable #CoronaryArteryDisease and at least moderate inducible ischemia, long-term follow-up from #ISCHEMIA supports a medical therapy–first approach for most patients.
ja.ma/4ep2QLb
#ScientificSessions26
📊 Research Summary from @JAMA_current: Long-term follow-up in #ISCHEMIA-EXTEND indicates no significant all-cause mortality difference between initial invasive and conservative management of stable #CoronaryDisease.
ja.ma/4kEJh59
#ScientificSessions26
Presented at #ScientificSessions26 from @JAMA_current: Among patients with stable #CoronaryDisease and moderate or severe ischemia, an initial invasive strategy did not improve long-term survival vs an initial conservative strategy.
ja.ma/4iu7iuq
#ScientificSessions26 from @JAMACardio: #AI analysis of clinical notes identified infrequent low-density lipoprotein cholesterol target documentation and heterogeneous reasons for nonescalation of #LipidLoweringTherapy in secondary prevention.
ja.ma/4zDOuis
📣 Stay connected with the JAMA Network at #ScientificSessions26!
Explore the latest cardiovascular research, featured articles, editor sessions, and attendee resources from the JAMA Network: ja.ma/4zISsq3
💬 Editorial from @JAMA_current: In patients with stable #CoronaryArteryDisease and at least moderate inducible ischemia, long-term follow-up from #ISCHEMIA supports a medical therapy–first approach for most patients.
ja.ma/4iA71F6
#ScientificSessions26
📊 Research Summary from @JAMA_current: Long-term follow-up in #ISCHEMIA-EXTEND indicates no significant all-cause mortality difference between initial invasive and conservative management of stable #CoronaryDisease.
ja.ma/4iLmgLx
#ScientificSessions26
Presented at #ScientificSessions26 from @JAMA_current: Among patients with stable #CoronaryDisease and moderate or severe ischemia, an initial invasive strategy did not improve long-term survival vs an initial conservative strategy.
ja.ma/4sUvUQI
#ScientificSessions26 from @JAMACardio: #AI analysis of clinical notes identified infrequent low-density lipoprotein cholesterol target documentation and heterogeneous reasons for nonescalation of #LipidLoweringTherapy in secondary prevention.
ja.ma/4iqGuLE
📣 Stay connected with the JAMA Network at #ScientificSessions26!
Explore the latest cardiovascular research, featured articles, editor sessions, and attendee resources from the JAMA Network: ja.ma/4kFbYit
From @JAMA_current: Among veterans with stable #CoronaryArteryDisease, upfront #PercutaneousCoronaryIntervention plus optimal medical therapy did not reduce long-term death or myocardial infarction vs optimal medical therapy alone.
ja.ma/4zzhCHH
#ScientificSessions26
📣 Stay connected with the JAMA Network at #ScientificSessions26!
Explore the latest cardiovascular research, featured articles, editor sessions, and attendee resources from the JAMA Network: ja.ma/4sMCclj
🎉 Exhibits at #AHA26 are open. Find @JAMA_current, @JAMACardio, @JAMAInternalMed, and @JAMANetworkOpen at booth 537.
Get recent articles, find out when you can meet our editors, and ask us about publishing opportunities and submitting your work.
ja.ma/4k33TEc
Attending #AHA26? Check out our page created for attendees.
🌟 Find recent articles and podcasts, find out when you can meet our editors, and get information For Authors on @JAMA_current, @JAMACardio, @JAMAInternalMed, and @JAMANetworkOpen.
ja.ma/4krtZAK
In 2027, JAMA will convene leaders across #medicine, research, #technology, industry, and #policy to address how #AI will reshape health care and biomedical science.
Learn more: ja.ma/4BHTvYI
#HealthAfterAI #JAMASummit


















